Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ·Healthcare·Biotechnology
$290.17
-2.06%
Mkt Cap $5.96B
Analyst Ratings
Buy
11
Hold
0
Sell
0
Price Target (20 analysts)
$291.00
Range $252.00 – $332.00
Implied Upside
+0.3%
Consensus $291.00 vs current $290.17